A decrease in albumin in early HIV type 1 infection predicts subsequent disease progression

AIDS Research and Human Retroviruses

Volumn 23, Issue 10, 2007, Pages 1197-1200

  Graham, Susan M ^a,b   Baeten, Jared M ^a   Richardson, Barbra A ^a   Wener, Mark H ^a   Lavreys, Ludo ^a,b   Mandaliya, Kishorchandra ^c   Ndinya Achola, Jeckoniah O ^b   Overbaugh, Julie ^d   McClelland, R Scott ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF NAIROBI   (Kenya)

^c Department of Obstetrics and Gynaecology   (Kenya)

^d Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; EVALUATION AND FOLLOW UP; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HYPOALBUMINEMIA; KENYA; MAJOR CLINICAL STUDY; MORTALITY; PREDICTION; PREVALENCE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; VIRUS LOAD; WILCOXON SIGNED RANKS TEST;

ADULT; CD4 LYMPHOCYTE COUNT; DISEASE PROGRESSION; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; KENYA; PREVALENCE; PROSTITUTION; SERUM ALBUMIN; VIRAL LOAD;

EID: 35548989770     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2007.0065     Document Type: Article

References (13)

1. Justice AC, Feinstein AR, and Wells CK: A new prognostic staging system for the acquired immunodeficiency syndrome. N Engl J Med 1989;320:1388-1393.
2. Feldman JG, Burns DN, Gange SJ, et al.: Serum albumin as a predictor of survival in HIV-infected women in the Women's Interagency HIV study. AIDS 2000;14:863-870.
3. Sabin CA, Giffioen A, Yee TT, et al.: Markers of HIV-1 disease progression in individuals with haemophilia coinfected with hepatitis C virus: A longitudinal study. Lancet 2002;360:1546-1551.
4. Mehta SH, Astemborski J, Sterling TR, et al.: Serum albumin as a prognostic indicator for HIV disease progression. AIDS Res Hum Retroviruses 2006;22:14-21.
5. Olawumi HO and Olatunji PO: The value of serum albumin in pretreatment assessment and monitoring of therapy in HIV/AIDS patients. HIV Med 2006;7:351-355.
6. Lavreys L, Baeten JM, Kreiss JK, et al.: Injectable contraceptive use and genital ulcer disease during the early phase of HIV-1 infection increase plasma virus load in women. J Infect Dis 2004;189:303-311.
7. Emery S, Bodrug S, Richardson BA, et al.: Evaluation of performance of the Gen-Probe human immunodeficiency virus type 1 viral load assay using primary subtype A, C, and D isolates from Kenya. J Clin Microbiol 2000;38:2688-2695.
8. Dati F, Schumann G, Thomas L, et al.: Consensus of a group of professional societies and diagnostic companies on guidelines for interim reference ranges for 14 proteins in serum based on the standardization against the IFCC/BCR/CAP Reference Material (CRM 470). Eur J Clin Chem Clin Biochem 1996;34:517-520.
9. Gabay C and Kushner I: Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999;340:448-454.
10. Feldman JG, Gange SJ, Bacchetti P, et al.: Serum albumin is a powerful predictor of survival in HIV-1 infected women. J Acquir Immune Defic Syndr 2003;33:66-73.
11. Lavreys L, Baeten JM, Chohan V, et al.: Higher set point plasma viral load and more-severe acute HIV type 1 (HIV-1) illness predict mortality among high-risk HIV-1-infected African women. Clin Infect Dis 2006;42:1333-1339.
12. Centlivre M, Sala M, Wain-Hobson S, and Bekhout B: In HIV-1 pathogenesis the die is cast during primary infection. AIDS 2007;21:1-11.
13. Brenchly JM, Price DA, Schacker TW, et al.: Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 2006;21:1365-1371.